Cipla Profit
-
{
- All
- News
- Videos
-
Sensex Breaks 7-Days Losing Streak, Rises 330 Points: 10 Things To Know
The stock markets snapped a seven-day losing streak on Thursday, with the BSE benchmark index Sensex closing 330 points higher at 34,413 and the NSE Nifty finishing at 10,576. The domestic shares tracked mostly higher Asian markets on Thursday. However, analysts say Indian markets are likely to remain volatile till the global equities settle down. ...
-
Sensex Closes Down 106 Points, Nifty Sheds 0.28%, Airtel, Infosys, Tata Motors Biggest Losers
Sensex closed106 points, 0.31%, lower to 33,619, Nifty shed29 points, or 0.28%, to close at 10,370 points.
-
Cipla Receives USFDA's Final Approval For Generic Dacogen
Cipla has received final approval for its ANDA for Decitabine Injection 50 mg single-use sterile vial from the US FDA
-
Sensex, Nifty Pare Early Gains, Trade Marginally Higher
Sensex and Nifty trade in narrow range on weakness in IT and metal stocks after participants took profit amid sluggish global pointers
-
Cipla Q2 Profit Soars 19 per Cent To Rs 423 Crore On Higher Domestic Sales
Cipla posted its second straight rise in quarterly profit, slightly above analysts' estimate, boosted by strong domestic sales.
-
Sensex Breaks 7-Days Losing Streak, Rises 330 Points: 10 Things To Know
The stock markets snapped a seven-day losing streak on Thursday, with the BSE benchmark index Sensex closing 330 points higher at 34,413 and the NSE Nifty finishing at 10,576. The domestic shares tracked mostly higher Asian markets on Thursday. However, analysts say Indian markets are likely to remain volatile till the global equities settle down. ...
-
Sensex Closes Down 106 Points, Nifty Sheds 0.28%, Airtel, Infosys, Tata Motors Biggest Losers
Sensex closed106 points, 0.31%, lower to 33,619, Nifty shed29 points, or 0.28%, to close at 10,370 points.
-
Cipla Receives USFDA's Final Approval For Generic Dacogen
Cipla has received final approval for its ANDA for Decitabine Injection 50 mg single-use sterile vial from the US FDA
-
Sensex, Nifty Pare Early Gains, Trade Marginally Higher
Sensex and Nifty trade in narrow range on weakness in IT and metal stocks after participants took profit amid sluggish global pointers
-
Cipla Q2 Profit Soars 19 per Cent To Rs 423 Crore On Higher Domestic Sales
Cipla posted its second straight rise in quarterly profit, slightly above analysts' estimate, boosted by strong domestic sales.
